RADIAL ACCESS FOR CORONARY INTERVENTION
Transradial Artery Access (TRA) for percutaneous coronary intervention (PCI) is proven to reduce associated bleeding and vascular complications; especially in patients with acute coronary syndromes (ACS).¹ Use of TRA for coronary angiography and PCI is also associated with improved measures of quality of life and reduced costs compared with Transfemoral Access. A growing body of evidence supports adoption of TRA to improve ACS-related outcomes, to improve healthcare quality, and to reduce cost.¹
RESOURCES
Coronary Artery Disease, or CAD, develops when the major blood vessels in the heart (coronary arteries) become damaged or diseased. Cholesterol-containing deposits (plaque) in arteries and inflammation are usually to blame for coronary artery disease.2 Below are a few articles demonstrating the benefit of radial access coronary procedures.
Need More Information?
We can help.
REFERENCES
- Valgimigli M, MATRIX Investigators. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet. 2015; 385:2465–2476.
- CDC, NCHS. Underlying Cause of Death 1999-2013 on CDC WONDER Online Database, released 2015. Data are from the Multiple Cause of Death Files, 1999-2013, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Accessed Feb. 3, 2015: https://wonder.cdc.gov/wonder/help/ucd.html.